Sort   by:  
 Page size 
UnknownPemetrexed and cisplatin for the treatment of advanced, persistent, or recurrent carcinoma of the cervix: a limited access phase II trial of the gynecologic oncology group.
Not available
S-EPMC4145184 | biostudies-literature
UnknownRandomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study.
Not available
S-EPMC4372854 | biostudies-literature
UnknownRecurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study.
Not available
S-EPMC3295548 | biostudies-literature
UnknownCognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.
Not available
S-EPMC4698796 | biostudies-literature
UnknownAn evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
Not available
S-EPMC5697899 | biostudies-literature
Sort   by:  
 Page size